EWTX
Edgewise Therapeutics, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth -26.7% ·
share flow +0.1% ·
net new positions -20.0%
· formula
Concentrated accumulation: rising shares among fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | +1 | 735.20K | $29.85M | +1 | n/a |
| Q2 2026 | 88 | +9 | 40.35M | $1.62B | +14 | −4 |
| Q1 2026 | 81 | +4 | 39.90M | $1.24B | +9 | −6 |
| Q4 2025 | 77 | +2 | 40.83M | $1.01B | +3 | n/a |
| Q3 2025 | 14 | +1 | 17.98M | $291.62M | +1 | −1 |
| Q2 2025 | 11 | -4 | 17.73M | $232.39M | n/a | −4 |
| Q1 2025 | 12 | -2 | 5.61M | $123.36M | n/a | −2 |
| Q4 2024 | 14 | 0 | 7.38M | $197.14M | +1 | −1 |
| Q3 2024 | 13 | +3 | 6.24M | $166.42M | +3 | n/a |
| Q2 2024 | 10 | n/a | 8.30M | $149.57M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passive) | 6.78M | n/a | $88.90M | 0.0% | n/c | 1 | SEC ↗ ×15 |
| 2 | The Vanguard Group ✦ (passive) | 4.84M | n/a | $63.47M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 3 | Geode Capital Management ✦ (passive) | 1.80M | +8.6% | $23.56M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 4 | State Street Global Advisors ✦ (passive) | 1.78M | +3.7% | $23.36M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Millennium Management ✦ | 921.97K | +49.9% | $12.09M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 6 | D. E. Shaw & Co. ✦ | 595.43K | +323.6% | $7.81M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 7 | Fidelity (FMR) ✦ | 470.72K | n/a | $6.17M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 8 | Citadel Advisors ✦ | 325.25K | +234.3% | $4.26M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 9 | Wellington Management ✦ | 112.57K | -0.7% | $1.48M | 0.0% | ▼ Trim | 5 | SEC ↗ ×4 |
| 10 | T. Rowe Price ✦ | 50.68K | -82.8% | $665,000 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 11 | Norges Bank ✦ (passive) | 47.76K | 0.0% | $626,068 | 0.0% | Held | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Viking Global Investors | $10.78M | was 0.0% |
| Adage Capital Partners | $8.58M | was 0.0% |
| Two Sigma Investments | $769,978 | was 0.0% |
| AQR Capital Management | $207,218 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 213 holders, 118.39M shares, $3.71B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 2.92K sh · $126,704
Officer · 2.17K sh · $95,075
Officer · 304 sh · $13,529
Officer · 150 sh · $6,666
Officer · 2.48K sh · $108,154
Officer · 2.84K sh · $124,303
Officer · 2.78K sh · $121,463
Officer · 104 sh · $4,620
Officer · 800 sh · $35,614
Officer, Director · 8.28K sh · $361,315
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology